Compass Therapeutics is rated Buy, with risk/reward favoring upside after a sharp post-data selloff. Click here to read more ...

Kelun-Biotech, listed under stock code 6990.HK, announced its Phase III OptiTROP-Lung06 trial of sac-TMT combined with ...

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing ...

As President Trump resumes his war, the focus is now on the Strait of Hormuz. But it remains unclear how far the U.S.

Delhi Metro has begun construction of the 12.37-km Inderlok-Indraprastha underground corridor, a Phase-IV project that will ...

India's economic fundamentals are stronger than they have been through much of the past two decades, but the country's next ...

Abstract: The three-phase dual-active bridge (DAB3) converter, a promising topology for high-power dc-dc conversion, suffers from transient overshoots and DC bias under conventional single phase-shift ...

Abstract: Current measurement error (CME) could lead to large torque ripple, increased losses, and reduced control performance. The long-term operation under heavy ...

aDepartment of Gastrointestinal Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada bDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer ...

cDepartment of Clinical Oncology, State Key Laboratory of Translational Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, ...